The current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but localized tumors have poorer long-term survival than those with melanoma that has spread to nearby lymph nodes, according to a large Swedish registry study from the University of Gothenburg.
This article was originally published on MedicalXpress.com

